查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1649461

精准医疗软体市场预测（2025-2030）

Precision Medicine Software Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

精准医疗软体市场规模预计将从 2025 年的 20.13 亿美元增至 2030 年的 31.86 亿美元，复合年增长率为 9.62%。

精准医疗，也称为个人化医疗，是一种针对疾病预防和治疗的客製化方法。它专注于预测疾病的易感性并预防疾病进展，减少药物处方中的试验并最大限度地减少副作用。精准医疗软体作为技术平台，为患者提供资料驱动的个人化治疗。全球癌症发生率的上升是预测期内推动精准医疗软体市场成长的关键因素。精准医疗透过提供患者个人化治疗在癌症治疗上有着重要的应用。此外，人工智慧（AI）在医疗保健领域的日益融入也是推动精准医疗软体需求的主要因素。世界各国都在实施重大政策和策略，以加强人工智慧在医疗保健领域的发展和融合。

精准医疗软体市场驱动因素：

  • 全球人工智慧技术的进步：人工智慧技术的快速进步是推动精准医疗软体市场扩张的主要因素。在技​​术创新的推动下，人工智慧技术领域正在经历显着成长。美国、加拿大、印度等国家政府都推出了各种政策和倡议来促进人工智慧的发展，尤其是在医疗保健领域。

例如，2024年9月，印度卫生与家庭福利部宣布与印度理工学院坎普尔分校和国家卫生服务局合作，为医疗保健领域的人工智慧应用开发数位公共产品。同样，2024 年 4 月，英国药品和保健品管理局 (MHRA) 发布了将人工智慧融入医疗保健的策略方针。

影响精准医疗软体市场的地理趋势：

  • 北美显着成长：预计预测期内北美地区将占据精准医疗软体市场的大部分份额。美国和加拿大等国家正在实施重大策略，将人工智慧纳入其医疗保健系统。癌症等慢性病的发生率不断上升，将进一步推动精准医疗技术的需求。

焦虑、忧郁症和创伤后压力症候群等精神疾病的发生率日益上升，迫切需要有效的治疗方案。新冠疫情加剧了这些挑战，并导致对心理健康服务的需求激增，因为人们在压力和不确定性增加的情况下寻求帮助。总之，由于人工智慧技术的进步、全球对慢性病有效治疗方法的需求不断增长、政府鼓励医疗技术创新的支持性政策以及有利的地理趋势（尤其是北美），市场格局预计将大幅增长，从而加强了这一不断扩大的市场环境。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 各地区（包括细分市场和国家）的收益成长和预测分析
  • 公司概况（策略、产品、财务、主要发展等）

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第 5 章 精准医疗软体市场（依部署）

  • 介绍
  • 云
  • 本地

第六章 精准医疗软体市场（依应用）

  • 介绍
  • 肿瘤学
  • 中枢神经系统
  • 免疫学
  • 心血管
  • 其他的

第 7 章 精准医疗软体市场（依最终用户划分）

  • 介绍
  • 医院和诊所
  • 药物研究设施
  • 其他的

第 8 章 精准医疗软体市场（按地区）

  • 介绍
  • 北美洲
    • 按部署
    • 按应用
    • 按最终用户
    • 按国家
  • 南美洲
    • 按部署
    • 按应用
    • 按最终用户
    • 按国家
  • 欧洲
    • 按部署
    • 按应用
    • 按最终用户
    • 按国家
  • 中东和非洲
    • 按部署
    • 按应用
    • 按最终用户
    • 按国家
  • 亚太地区
    • 按部署
    • 按应用
    • 按最终用户
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Accenture
  • Wipro
  • Intel
  • GenomOncology LLC
  • Precision Medicine Group, LLC.
  • Tempus
  • Genomind
  • Syapse Holdings, Inc.
  • Foundation Medicine, Inc.
  • 2bPrecise
  • Koninklijke Philips NV
  • Cision US Inc.
  • Genedata AG
  • Ariel Precision Medicine
  • Integrate.AI Inc.
简介目录
Product Code: KSI061617237

The precision medicine software market is estimated to grow at a CAGR of 9.62%, attaining US$3.186 billion by 2030, from US$2.013 billion in 2025.

Precision medicine is a tailored approach to disease prevention and treatment, also known as personalized medicine. It focuses on predicting susceptibility to diseases and preventing disease progression, reducing the trial-and-error nature of drug prescribing and minimizing adverse drug reactions. Precision medicine software serves as a technological platform that provides data-driven, personalized treatment for patients. The rising global incidence of cancer is a significant factor driving the growth of the precision medicine software market during the forecast period.Precision medicine has crucial applications in cancer treatment by offering personalized therapies to patients. Additionally, the increasing integration of artificial intelligence (AI) into healthcare is another major driver of demand for precision medicine software. Countries worldwide are implementing key policies and strategies to enhance the development and integration of AI within the healthcare sector.

Drivers of the Precision Medicine Software Market:

  • Advancements in Global AI Technology: The rapid advancement of artificial intelligence technologies is a primary factor fueling the expansion of the precision medicine software market. The AI technology sector has seen substantial growth, driven by innovations in technology. Governments in countries such as the USA, Canada, and India have introduced various policies and initiatives to promote AI development, particularly in healthcare.

For instance, in September 2024, India's Ministry of Health and Family Welfare announced a collaboration with IIT Kanpur and the National Health Authority to develop digital public goods for AI applications in healthcare. Similarly, in April 2024, the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) released its strategic approach to integrating AI into healthcare.

Geographical Trends Shaping the Precision Medicine Software Market:

  • Significant Growth in North America: The North American region is expected to hold a substantial share of the precision medicine software market during the forecast period. Countries like the USA and Canada have implemented key strategies to incorporate artificial intelligence into their healthcare systems. The increasing prevalence of chronic diseases, including cancer, further drives demand for precision medicine technologies.

The growing incidence of mental health disorders such as anxiety, depression, and PTSD has created an urgent need for effective treatment options. The COVID-19 pandemic exacerbated these challenges, leading to a surge in demand for mental health services as individuals sought help during heightened stress and uncertainty.In summary, the precision medicine software market is poised for significant growth driven by advancements in AI technology, rising global demand for effective treatments for chronic diseases, supportive governmental initiatives promoting innovation in healthcare technologies, and favorable geographical trends-particularly within North America-that enhance this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Precision Medicine Software Market is segmented and analyzed as follows:

By Deployment

  • Cloud
  • On-Premise

By Application

  • Oncology
  • Central Nervous System
  • Immunology
  • Cardiovascular
  • Others

By End User

  • Hospitals and Clinics
  • Pharmaceutical Research Institute
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • Australia
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. PRECISION MEDICINE SOFTWARE MARKET BY DEPLOYMENT

  • 5.1. Introduction
  • 5.2. Cloud
  • 5.3. On-Premise

6. PRECISION MEDICINE SOFTWARE MARKET BY APPLICATIONS

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Central Nervous System
  • 6.4. Immunology
  • 6.5. Cardiovascular
  • 6.6. Others

7. PRECISION MEDICINE SOFTWARE MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Pharmaceutical Research Institute
  • 7.4. Others

8. PRECISION MEDICINE SOFTWARE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Deployment
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Deployment
    • 8.3.2. By Application
    • 8.3.3. By End User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Deployment
    • 8.4.2. By Application
    • 8.4.3. By End User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. Spain
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. France
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Deployment
    • 8.5.2. By Application
    • 8.5.3. By End User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. South Africa
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Deployment
    • 8.6.2. By Application
    • 8.6.3. By End User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. Australia
      • 8.6.4.4. India
      • 8.6.4.5. South Korea
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Accenture
  • 10.2. Wipro
  • 10.3. Intel
  • 10.4. GenomOncology LLC
  • 10.5. Precision Medicine Group, LLC.
  • 10.6. Tempus
  • 10.7. Genomind
  • 10.8. Syapse Holdings, Inc.
  • 10.9. Foundation Medicine, Inc.
  • 10.10. 2bPrecise
  • 10.11. Koninklijke Philips N.V
  • 10.12. Cision US Inc.
  • 10.13. Genedata AG
  • 10.14. Ariel Precision Medicine
  • 10.15. Integrate.AI Inc.